Event Brief
Research team confirms safety of Alzheimer's drug Lecanemab
Filed: Mar 25, 2026 at 2:03 AM ET
Summary: A study shows over 90% of patients in Japan can continue Lecanemab treatment without severe side effects.
WHO: Research team
WHAT: Confirmed safety of Alzheimer's drug Lecanemab
WHEN: Mar 25, 2026 at 1:39 AM ET
WHERE: Japan
WHY: To assess the health status of patients after treatment with Lecanemab.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →